These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9759937)
1. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro. Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937 [TBL] [Abstract][Full Text] [Related]
2. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector. Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122 [TBL] [Abstract][Full Text] [Related]
3. Transduction of fibroblasts and CD34+ progenitors using a selectable retroviral vector containing cDNAs encoding arylsulfatase A and CD24. Tsutsudaasano A; Migita M; Takahashi K; Shimada T J Hum Genet; 2000; 45(1):18-23. PubMed ID: 10697958 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for metachromatic leukodystrophy. Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Matalon R; Eto Y Acta Paediatr Jpn; 1996 Apr; 38(2):193-201. PubMed ID: 8677802 [TBL] [Abstract][Full Text] [Related]
5. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy. Takakusaki Y; Hisayasu S; Hirai Y; Shimada T Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells. Matzner U; Schestag F; Hartmann D; Lüllmann-Rauch R; D'Hooge R; De Deyn PP; Gieselmann V Hum Gene Ther; 2001 Jun; 12(9):1021-33. PubMed ID: 11399225 [TBL] [Abstract][Full Text] [Related]
8. In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells. Lagranha VL; Baldo G; de Carvalho TG; Burin M; Saraiva-Pereira ML; Matte U; Giugliani R Metab Brain Dis; 2008 Dec; 23(4):469-84. PubMed ID: 18797988 [TBL] [Abstract][Full Text] [Related]
9. Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells. Matzner U; Habetha M; Gieselmann V Gene Ther; 2000 May; 7(9):805-12. PubMed ID: 10822308 [TBL] [Abstract][Full Text] [Related]
10. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy. Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647 [TBL] [Abstract][Full Text] [Related]
12. Correction of enzyme deficiency in metachromatic leukodystrophy fibroblasts by retroviral-mediated transfer of the human arylsulphatase A gene. Ohashi T; Eto Y; Learish R; Barranger JA J Inherit Metab Dis; 1993; 16(5):881-5. PubMed ID: 7905036 [No Abstract] [Full Text] [Related]
13. Gene therapy in metachromatic leukodystrophy. Sevin C; Cartier-Lacave N; Aubourg P Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324 [TBL] [Abstract][Full Text] [Related]
15. An assay for the rapid detection of the arylsulfatase A pseudodeficiency allele facilitates diagnosis and genetic counseling for metachromatic leukodystrophy. Gieselmann V Hum Genet; 1991 Jan; 86(3):251-5. PubMed ID: 1671769 [TBL] [Abstract][Full Text] [Related]
16. Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy. Yaghootfam C; Sylvester M; Turk B; Gieselmann V; Matzner U Mol Ther; 2023 Oct; 31(10):2962-2974. PubMed ID: 37644722 [TBL] [Abstract][Full Text] [Related]
17. Genetic complementation in somatic cell hybrids of cerebroside sulfatase activator deficiency and metachromatic leukodystrophy fibroblasts. Kihara H; Tsay KK; Fluharty AL Hum Genet; 1984; 66(4):300-1. PubMed ID: 6144627 [TBL] [Abstract][Full Text] [Related]
18. Developing therapeutic approaches for metachromatic leukodystrophy. Patil SA; Maegawa GH Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723 [TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of metachromatic leukodystrophy. Gieselmann V; Polten A; Kreysing J; Kappler J; Fluharty A; von Figura K Dev Neurosci; 1991; 13(4-5):222-7. PubMed ID: 1687778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]